Bevisning gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Säkerhet caps applied after weighting.
This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.
The specific product: dose, price, transparency, and what buyers report.
Säkerhet flags, transparency gaps, dosing concerns, and recurring buyer complaints.
All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Bevisning grades are reviewed when new human RCTs are published. Read how we verify.
Consumer signals gathered from 2 platforms.
Medium confidence169 reviews · 3.8/5 · mixed sentiment
Compiled from a Trustpilot listing located during research; verified at build time.
1 threads discussed · mixed sentiment
Compiled from a Reddit r/NMN listing located during research; verified at build time.
These are consumer sentiment signals. They do not measure whether the product actually works. See our evidence section for that.
Public sources on this same product, unrelated to NO1GEVITY. NIH DSLD is the US government's registered label database (shown verbatim). SuppCo.com is a separate, unaffiliated commercial site with no partnership or data-sharing arrangement with us. NO1GEVITY scores are computed independently of both.
SuppCo is a separate, unaffiliated supplement-tracking site with no partnership, data-sharing agreement, or business relationship with NO1GEVITY. We are not endorsed by them and they do not endorse us. The two facts below are individually verified against the manufacturer or NSF; the outbound link is provided only so readers can independently cross-check on a third-party site if they want to.
No external reviews aggregated yet for this product.
The studies that established the trial dose and evidence grade for each active ingredient in this product. Click through to read the original paper.
Capsules are dosed at only 125 mg/capsule (250 mg/day at standard 2-cap serving), on the low end of the 250-1000 mg human research range. No separate 500 mg capsule SKU exists; higher doses require taking 4+ capsules or switching to the powder format. Priced high per mg ($48.95 for 60 caps = 15g total NMN) relative to category median.
This Double Wood Supplements NMN Supplement (Nicotinamide Mononucleotide) scores 6.9, making it a mid-tier product with both strengths and weaknesses. It delivers 250.0mg of NMN (50% of the 500mg trial dose) with grade B evidence (promising human data, not yet comprehensive). Transparency is a clear strength (score: 9.0), with third-party testing and a public analysintyg. At $1.63/day it's among the more expensive options in NAD+ precursor.
If you are the manufacturer or brand owner of NMN Supplement (Nicotinamide Mononucleotide) and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.
We review every request, verify it against primär sources, and publish any change with a dated note in the version history above. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.
Request a correction →The next highest-scoring produkter in NAD+ precursor, same scoring method, same rules.